Midwife quit over 'unsafe care' and staffing
Other NHS workers have risen in number five times more than midwives over the past decade.
Similar Posts
Gene therapy breakthrough restores hearing in some deaf children
Gene therapy has successfully restored hearing in some children born with inherited deafness, health officials say. A study in China and another at the Children’s Hospital of Philadelphia documented significant improvements in hearing in treated children. Cochlear implants are commonly used for children with hereditary deafness, but gene therapy offers a potential treatment. Gene therapy…
Covid and flu winter jabs to be brought forward in England
As in previous years, the NHS will let people know when bookings open. Adult flu and COVID-19 appointments will be available through the NHS App and website, or by calling 119 for those who can’t get online. Flu vaccines will also be available through local GP practices and pharmacies. Flu vaccinations for children which will…
Boehringer Ingelheim, Terns, Viking may join market
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead the market for popular weight loss drugs, which could…
Cold weather: How do cold-health alerts work?
The UK Health Security Agency has issued an amber cold-health alert for the whole of England.
Mental health may be worse in teens from large families, study suggests: ‘Fewer resources’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Moderna stock jumps after Oppenheimer upgrade on pipeline potential
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…